| 货号 | 600090-480Well |
| 描述 | Mammalian soluble epoxide hydrolase (sEH) is a member of the α/β-hydrolase fold family of enzymes that catalyze the hydrolysis of exogenous and endogenous epoxides to vicinal diols. sEH is a homodimer consisting of two domains.1 The C-terminal domain is responsible for the epoxide hydrolase activity while the N-terminal domain has a catalytic center with phosphatase activity. Endogenous substrates for sEH include epoxyeicosatrienoic acids (EETs) which exhibit vasodilatory and anti-inflammatory activity.2 Inhibition of sEH in animal models was shown to effectively treat hypertension and vascular inflammation as well as related syndromes.3 These studies demonstrate the value for targeting sEH for development of small molecule inhibitors as therapeutics. Cayman’s sEH Cell-Based Assay Kit provides a convenient 96-well plate, fluorescence-based method for detecting epoxide hydrolase activity in whole cells. The assay utilizes Epoxy Fluor 7, a sensitive fluorescent substrate for sEH that can be used to monitor the activity of both human and murine enzymes.4 Hydrolysis of the substrate epoxide yields a highly fluorescent product, 6-methoxy-2-Naphthaldehyde, that can be monitored at excitation and emission wavelengths of 330 and 465 nm, respectively. 6-Methoxy-2-Naphthaldehyde is included to quantify enzyme activity and a recombinant sEH is included as a positive control. An sEH inhibitor AUDA is also included for checking specificity of the reaction. This assay parallels Cayman’s Soluble Epoxide Hydrolase Inhibitor Screening Assay Kit (Catalog No. 10011671) which uses recombinant protein rather than whole cells for the assay. Together, both assays will help to identify whether or not an inhibitor/activator has a direct or indirect effect on the enzyme. |
| 别名 | Cytosolic Epoxide Hydrolase (CEH);EPHX2;Epoxide Hydrolase 2;sEH; |
| 供应商 | Cayman |
| 应用文献 | |
| 1.Chiamvimonvat, N.,Ho, C.M.,Tsai, H.J., et al. The soluble epoxide hydrolase as a pharmaceutical target for hypertension. Journal of Cardiovascular Pharmacology 50(3), 225-237 (2007). 2.Yu, Z.,Xu, F.,Huse, L.M., et al. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circulation Research 87, 992-998 (2000). 3.Imig, J.D.,Zhao, X.,Zaharis, C.Z., et al. An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension. Hypertension 46(2), 975-981 (2005). 4.Jones, P.D.,Wolf, N.M.,Morisseau, C., et al. Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies. Analytical Biochemistry 343, 66-75 (2005). | |
| 运输条件 | Dry ice in continental US; may vary elsewhere |
| 存放说明 | -80 |
| 稳定性 | ≥ 1 year |
| 本官网所有报价均为常温或者蓝冰运输价格，如有产品需要干冰运输，需另外加收干冰运输费。 |